Kelly Shi
Stock Analyst at Jefferies
(3.01)
# 1,349
Out of 5,056 analysts
33
Total ratings
45.16%
Success rate
12.14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $75.72 | +1.69% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $200.84 | -26.31% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $33.81 | -17.18% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $16.41 | +168.21% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $9.19 | +63.22% | 1 | Apr 10, 2025 | |
| OPT Opthea | Downgrades: Underperform | $1 | $3.41 | -70.67% | 1 | Mar 25, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $12.14 | +328.34% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.94 | +183.40% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $27.87 | -31.83% | 2 | Sep 11, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $174 → $196 | $211.32 | -7.25% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $3.49 | +501.72% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $16.87 | +119.32% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.31 | +159.74% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $101.70 | -20.35% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $20.11 | +74.04% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.23 | +1,517.98% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $13.24 | +20.85% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $64.72 | -38.20% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $13.92 | +43.64% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.17 | +269.52% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.60 | +4,393.26% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $14.50 | +258.74% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.67 | +911.24% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.81 | +1,723.20% | 1 | Mar 8, 2021 |
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $75.72
Upside: +1.69%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $200.84
Upside: -26.31%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $33.81
Upside: -17.18%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $16.41
Upside: +168.21%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $9.19
Upside: +63.22%
Opthea
Mar 25, 2025
Downgrades: Underperform
Price Target: $1
Current: $3.41
Upside: -70.67%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $12.14
Upside: +328.34%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.94
Upside: +183.40%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $27.87
Upside: -31.83%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $211.32
Upside: -7.25%
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $3.49
Upside: +501.72%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $16.87
Upside: +119.32%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.31
Upside: +159.74%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $101.70
Upside: -20.35%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $20.11
Upside: +74.04%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $2.23
Upside: +1,517.98%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $13.24
Upside: +20.85%
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $64.72
Upside: -38.20%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $13.92
Upside: +43.64%
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $2.17
Upside: +269.52%
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $0.60
Upside: +4,393.26%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $14.50
Upside: +258.74%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.67
Upside: +911.24%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.81
Upside: +1,723.20%